US Stock MarketDetailed Quotes
TBPH Theravance Biopharma
- 9.470
- 0.0000.00%
Close Nov 25 16:00 ET
- 9.470
- 0.0000.00%
Post 16:13 ET
465.68MMarket Cap-9194P/E (TTM)
9.760High9.470Low240.13KVolume9.520Open9.470Pre Close2.29MTurnover1.14%Turnover RatioLossP/E (Static)49.17MShares11.71052wk High2.51P/B199.59MFloat Cap7.44052wk Low--Dividend TTM21.08MShs Float124.866Historical High--Div YieldTTM3.06%Amplitude6.100Historical Low9.541Avg Price1Lot Size
About Theravance Biopharma Company
Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.
Company Profile
SymbolTBPH
Company NameTheravance Biopharma
Listing DateMay 16, 2014
Founded2013
CEOMr. Rick E. Winningham
MarketNASDAQ
Employees99
Fiscal Year Ends12-31
Address901 Gateway Boulevard
CitySouth San
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-808-6000
Websitehttp://www.theravance.com
Company Executives
- Name
- Position
- Salary
- Rick E. Winningham
- Chief Executive Officer and Chairman of the Board
- 1.30M
- Aziz Sawaf
- Senior Vice President, Chief Financial Officer and Principal Accounting Officer
- 583.50K
- Rhonda Farnum
- Chief Business Officer and Senior Vice President, Commercial and Medical Affairs
- --
- Dr. Aine Miller, PhD
- Senior Vice President, Development and Head of Ireland Office
- --
- Brett A. Grimaud
- Senior Vice President, General Counsel and Secretary
- --
- Donal O’Connor
- Independent Director
- 195.80K
- Dean Jonathan Mitchell
- Lead Independent Director
- 211.73K
- Eran Broshy
- Independent Director
- 205.14K
- James C. Kelly
- Independent Director
- 43.10K
- Susannah Gray, M.B.A.
- Independent Director
- 346.47K
- Dr. Laurie Smaldone Alsup, M.D.
- Independent Director
- 197.68K
- Dr. Deepika Rachel Pakianathan
- Independent Director
- 207.68K
- Jeremy Grant
- Independent Director
- 168.36K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data